Cross-sectional analyses revealed significant modulation of the genes CYP4F22, LYPD3, PMP22, and MAP1LC3C between controls and T1D patients classified as decliners and non-decliners (Supplemental Figure 2). The gene discussed is CYP4F22; the disease is type 1 diabetes mellitus.